Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan-Reference-Cited by-同舟云学术

Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan

Published:2020-09-01 Issue:5 Volume:35 Page:338-347
ISSN:1548-9213
Container-title:Physiology
language:en
Short-container-title:Physiology

Author:

Miller Benjamin F.¹²³^ORCID,Thyfault John P.⁴⁵⁶

Affiliation:

1. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma

2. Oklahoma Nathan Shock Center for Aging, Oklahoma City, Oklahoma

3. Harold Hamm Diabetes Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

4. Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas

5. Research Service, Kansas City VA Medical Center, Kansas City, Missouri

6. Center for Children’s Healthy Lifestyle and Nutrition, Children’s Mercy Hospital, Kansas City, Missouri

Abstract

There is an increased focus on treatments to extend the healthspan. There is solid evidence that exercise extends the healthspan, but other treatments, such as metformin and statins, are also gaining traction. If metformin and statins will be used to prolong healthspan, we must understand their effects in those free of disease and in combination with exercise.

Funder

Office of Extramural Research, National Institutes of Health

Center for Integrated Healthcare, U.S. Department of Veterans Affairs

Publisher

American Physiological Society

Subject

Physiology

Link

https://journals.physiology.org/doi/pdf/10.1152/physiol.00013.2020

Reference94 articles.

1. Should people at low risk of cardiovascular disease take a statin?

2. 8. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2018